| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adrenal tracer uptake by 18F-FDOPA PET/CT in patients with pheochromocytoma and controls
|
Noordzij, Walter
|
|
2019
|
46 |
7 |
p. 1560-1566
|
article
|
| 2 |
Breaking an unhelpful circle, where innovation and regularia delay clinical practice for patient benefit
|
Ell, Peter
|
|
2019
|
46 |
7 |
p. 1397-1398
|
article
|
| 3 |
Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?
|
Voglimacci, Marie
|
|
2019
|
46 |
7 |
p. 1551-1559
|
article
|
| 4 |
Clinical utility of 68Ga-DOTATOC positron emission tomography/computed tomography for recurrent renal cell carcinoma
|
Nakamoto, Yuji
|
|
2019
|
46 |
7 |
p. 1524-1530
|
article
|
| 5 |
Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma
|
Hofheinz, Frank
|
|
2019
|
46 |
7 |
p. 1485-1494
|
article
|
| 6 |
Correction to: 18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions
|
Humbert, Olivier
|
|
2019
|
46 |
7 |
p. 1581
|
article
|
| 7 |
Detection of cardiac amyloidosis with 18F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy
|
Kircher, Malte
|
|
2019
|
46 |
7 |
p. 1407-1416
|
article
|
| 8 |
Development and validation of the PET-CT score for diagnosis of malignant pleural effusion
|
Yang, Min-Fu
|
|
2019
|
46 |
7 |
p. 1457-1467
|
article
|
| 9 |
Diagnostic performance of 68Ga-PSMA PET/CT for identification of aggressive cribriform morphology in prostate cancer with whole-mount sections
|
Gao, Jie
|
|
2019
|
46 |
7 |
p. 1531-1541
|
article
|
| 10 |
Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma
|
Genolla, Jose
|
|
2019
|
46 |
7 |
p. 1567-1575
|
article
|
| 11 |
EANM Focus 1: one small step for two men, one giant leap for a specialty
|
Fanti, Stefano
|
|
2019
|
46 |
7 |
p. 1400-1401
|
article
|
| 12 |
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines
|
Elsinga, Philip
|
|
2019
|
46 |
7 |
p. 1399
|
article
|
| 13 |
Exploratory radiomic features from integrated 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging are associated with contemporaneous metastases in oesophageal/gastroesophageal cancer
|
Baiocco, Serena
|
|
2019
|
46 |
7 |
p. 1478-1484
|
article
|
| 14 |
18F-FDG uptake of brown fat and cancer: casualty or causality?
|
Gennaro, Nicolò
|
|
2019
|
46 |
7 |
p. 1395-1396
|
article
|
| 15 |
18F-FPPRGD2 PET/CT in patients with metastatic renal cell cancer
|
Toriihara, Akira
|
|
2019
|
46 |
7 |
p. 1518-1523
|
article
|
| 16 |
One-stop shopping 18F-FDG PET/CT in a patient with vascular type Behçet’s disease
|
Norikane, Takashi
|
|
2019
|
46 |
7 |
p. 1578-1580
|
article
|
| 17 |
Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer
|
Ankersmit, M.
|
|
2019
|
46 |
7 |
p. 1495-1505
|
article
|
| 18 |
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy
|
Antunovic, Lidija
|
|
2019
|
46 |
7 |
p. 1468-1477
|
article
|
| 19 |
Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with 188Re-SSS Lipiodol radioembolization
|
Delaunay, Kostas
|
|
2019
|
46 |
7 |
p. 1506-1517
|
article
|
| 20 |
Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial
|
Guberina, Maja
|
|
2019
|
46 |
7 |
p. 1439-1447
|
article
|
| 21 |
Prognostic value of metabolic tumour volume on baseline 18F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification of the group with a high-risk NCCN-IPI
|
Shagera, Qaid Ahmed
|
|
2019
|
46 |
7 |
p. 1417-1427
|
article
|
| 22 |
Prospective comparison of whole-body MRI and 68Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy
|
Sawicki, Lino M.
|
|
2019
|
46 |
7 |
p. 1542-1550
|
article
|
| 23 |
Pseudoprogression on PSMA PET imaging of a mCRPC patient under anti-PD1 treatment
|
Costa, Larissa Bastos
|
|
2019
|
46 |
7 |
p. 1576-1577
|
article
|
| 24 |
Radiotherapy boost in patients with hypoxic lesions identified by 18F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up]
|
Vera, Pierre
|
|
2019
|
46 |
7 |
p. 1448-1456
|
article
|
| 25 |
Time for new imaging and therapeutic approaches in cardiac amyloidosis
|
Slart, Riemer H. J. A.
|
|
2019
|
46 |
7 |
p. 1402-1406
|
article
|
| 26 |
TSH suppression aggravates arterial inflammation — an 18F-FDG PET study in thyroid carcinoma patients
|
Boswijk, Ellen
|
|
2019
|
46 |
7 |
p. 1428-1438
|
article
|
Journal description